Cited In for PMID: 18242413

Year	Number of Results
2008	3
2009	15
2010	13
2011	12
2012	19
2013	16
2014	10
2015	21
2016	22
2017	15
2018	21
2019	22
2020	13
2021	25
2022	19
2023	18
2024	14
2025	20
2026	2

1

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial.

Kuter DJ, Bussel JB, Lyons RM, Pullarkat V, Gernsheimer TB, Senecal FM, Aledort LM, George JN, Kessler CM, Sanz MA, Liebman HA, Slovick FT, de Wolf JT, Bourgeois E, Guthrie TH Jr, Newland A, Wasser JS, Hamburg SI, Grande C, Lefrère F, Lichtin AE, Tarantino MD, Terebelo HR, Viallard JF, Cuevas FJ, Go RS, Henry DH, Redner RL, Rice L, Schipperus MR, Guo DM, Nichol JL. Kuter DJ, et al. Lancet. 2008 Feb 2;371(9610):395-403. doi: 10.1016/S0140-6736(08)60203-2. Lancet. 2008. PMID: 18242413 Clinical Trial.

2

Recombinant Protein Drugs: A 2025 Update.

López-Laguna H, Parladé E, Favaro MTP, Palacín C, Voltà-Durán E, Ferrer-Miralles N, Corchero JL, Rodríguez-Rodríguez R, Vázquez E, Unzueta U, Villaverde A. López-Laguna H, et al. BioDrugs. 2026 Jul;40(4):673-692. doi: 10.1007/s40259-026-00783-z. Epub 2026 May 13. BioDrugs. 2026. PMID: 42129013 Free PMC article. Review.

3

Successful Management of Relapsed Severe Immune Thrombocytopenia Using Avatrombopag: A Case Report.

Almutairi S, Warsi A, Hejazi A, Melibari E, Jar R, Almutairi A, Abughasham A, Firaque N. Almutairi S, et al. Case Rep Hematol. 2026 Feb 5;2026:2475501. doi: 10.1155/crh/2475501. eCollection 2026. Case Rep Hematol. 2026. PMID: 41659023 Free PMC article.

4

An Umbrella Review of Meta-Analyses on the Efficacy and Safety of Eltrombopag in Immune Thrombocytopenia.

Dabir M, Mousavi MK, Manteghi S, Mansoori MA, Karpasand F, Zoghi F, Payandeh M. Dabir M, et al. Health Sci Rep. 2025 Dec 14;8(12):e71429. doi: 10.1002/hsr2.71429. eCollection 2025 Dec. Health Sci Rep. 2025. PMID: 41403576 Free PMC article. Review.

5

Protein-Ligand Interactions in Cardiometabolic Drug Targets: Focus on Weight Loss and Cardioprotection.

Petsas E, Kiouri DP, Georgiou N, Siasos G, Mavromoustakos T, Chasapis CT. Petsas E, et al. Molecules. 2025 Oct 30;30(21):4240. doi: 10.3390/molecules30214240. Molecules. 2025. PMID: 41226200 Free PMC article. Review.

6

Anti-CD38 monoclonal antibody CM313 for primary immune thrombocytopenia: multicentre, randomised, placebo controlled, phase 2 trial.

Chen Y, Xu Y, Dai J, Sun T, Li H, Hua Z, Zhou Z, Zhou H, Yan Z, Zhao X, Xue F, Liu W, Liu X, Fu R, Wang W, Chi Y, Dong H, Ju M, Dai X, Gu W, Pei X, Yang R, Zhang L. Chen Y, et al. BMJ. 2025 Oct 21;391:e084314. doi: 10.1136/bmj-2025-084314. BMJ. 2025. PMID: 41120215 Free PMC article. Clinical Trial.

7

Bridging the gaps between randomized controlled trials and real-world use of thrombopoietin receptor agonists for adult primary immune thrombocytopenia: a systematic review and meta-analysis.

Luo L, Jin S, Song Z, Chong G, Ding H, Zeng S, Dai M, Wu M. Luo L, et al. Front Med (Lausanne). 2025 Sep 24;12:1667457. doi: 10.3389/fmed.2025.1667457. eCollection 2025. Front Med (Lausanne). 2025. PMID: 41070063 Free PMC article.

8

An unconquered challenge in MDS: review of pathophysiology, clinical manifestations, and management options of MDS with thrombocytopenia.

Chen X, Shukla M, Choi JH. Chen X, et al. Ann Hematol. 2025 Sep;104(9):4319-4332. doi: 10.1007/s00277-025-06374-2. Epub 2025 Sep 12. Ann Hematol. 2025. PMID: 40935929 Free PMC article. Review.

9

Impact of Primary Chronic Immune Thrombocytopenia and Thrombopoietin Receptor Agonists Treatment Instructions on Daily Living: Results of a Multinational Cross-Sectional Survey.

Zwaginga JJ, Nagalla S, Linden M, Lindberg MH, Kruse C, Morgan M, Yssing C, Decise D, Putnik M, Rich C. Zwaginga JJ, et al. Patient Prefer Adherence. 2025 Aug 13;19:2445-2458. doi: 10.2147/PPA.S505337. eCollection 2025. Patient Prefer Adherence. 2025. PMID: 40827208 Free PMC article.

10

Evaluating rilzabrutinib in the treatment of immune thrombocytopenia.

Kuter DJ, Ghanima W. Kuter DJ, et al. Immunotherapy. 2025 Aug;17(11):767-782. doi: 10.1080/1750743X.2025.2545170. Epub 2025 Aug 11. Immunotherapy. 2025. PMID: 40788289 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

269 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Cited In for PMID: 18242413

269 results

Results by year